[¸é¿ªÇйÙÀÌ¿ÀÆÀÀå]´ëÀü ´ë±â¾÷¹ÙÀÌ¿À»óÀå»ç

¸ðÁýºÎ¹® ¹× ÀÚ°Ý¿ä°Ç

¸ðÁýºÎ¹® ´ã´ç¾÷¹« ÀÚ°Ý¿ä°Ç Àοø
¸é¿ªÇйÙÀÌ¿ÀÆÀÀå

[´ã´ç¾÷¹«]

- °úÇÐÀû Àü¹® Áö½Ä, ÀÚ·á Á¶»ç, ÆÀÀÇ ½ÇÇè °á°ú¸¦ ¹ÙÅÁÀ¸·Î ÇÁ·ÎÁ§Æ® ¹æÇ⼺ ¼³Á¤
- ½Å±Ô °úÁ¦ ¹ß±¼
- ¿¬±¸º¸°í¼­ ¹× ÇÁ·ÎÁ§Æ® ÇÁ·¹Á¨Å×ÀÌ¼Ç Áغñ ÁÖµµ
- ¿¬±¸ÀÇ ¼³°è ¹× ½ÇÇèÀû ±¸Çö Áöħ Á¦°ø
- ÆÀ¿øÀÇ ¸àÅ丵 Á¦°ø(drug discovery¿¡ ÃÊÁ¡À» ¸ÂÃá ÆÀÀ» À̲ô´Â ¿ªÇÒ)

[ÀÚ°Ý¿ä°Ç]

- PhD in immunology

- 15+/ 10+ years of research experience in the field of immunology

- Work experience (5+ years in immuno-oncology preferred) in a drug discovery setting in industry

- Fluent in Korean and English

[  Skill ]

- Deep understanding of drug development process from discovery to clinical studies

- Strong leadership and communication skills

- Ability to work with multiple cross-functional teams

- Excellent decision-making skills


0 ¸í

±Ù¹«Á¶°Ç

  • °í¿ëÇüÅÂ: Á¤±ÔÁ÷
  • ±Þ¿©Á¶°Ç: ȸ»ç³»±Ô ÇùÀÇ ÈÄ °áÁ¤

ÀüÇü´Ü°è ¹× Á¦Ãâ¼­·ù

  • ÀüÇü´Ü°è: ¼­·ùÀüÇü > ¸éÁ¢ÁøÇà > ÃÖÁ¾½É»ç > ÃÖÁ¾ÇÕ°Ý
  • Ãß°¡ Á¦Ãâ¼­·ù
    À̷¼­, ÀÚ±â¼Ò°³¼­

Á¢¼ö¹æ¹ý

2024-10-26 (Åä) 23½Ã59ºÐ±îÁö

  • Á¢¼ö¹æ¹ý: ÀÎÅ©·çÆ® ä¿ë½Ã½ºÅÛ
  • Á¢¼ö¾ç½Ä: ÀÎÅ©·çÆ® À̷¼­

±âŸ À¯ÀÇ»çÇ×

  • ÀÔ»çÁö¿ø¼­ ¹× Á¦Ãâ¼­·ù¿¡ ÇãÀ§»ç½ÇÀÌ ÀÖÀ» °æ¿ì ä¿ëÀÌ Ãë¼ÒµÉ ¼ö ÀÖ½À´Ï´Ù.

00